This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.

Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

  • Products
  • Therapy Areas
  • Resources
  • Events & Webinars
  • Learning Zone
  • Podcasts
    Nubeqa New Banner-V4

    PROSTATE CANCER GUIDELINES

    Shared below is a directory to some national and international guidelines, and other informative sources, to provide further information to support you in your role in the management and treatment of advanced prostate cancer patients.

    Please note by clicking the link you will be directed to an external website, not owned by Bayer.

    NICE Guidelines Prostate Cancer

    Click to explore

    EAU Guidelines Prostate Cancer

    Click to explore

    PROSTATE CANCER UK

    Click to explore
    Health Hand Icon

    What are the NICE and SMC guidelines for NUBEQA?

    How much does darolutamide cost in the UK?

    Learn about NUBEQA Guidelines in Prostate Cancer
    Individual with plus symbol icon

    Further downloadable resources to support 

    you and your patients:

    Discover Downloadable Resources to support you and your patients

    Abbreviations

    NICE, National Institute for Health and Care Excellence; EAU, European Association of Urology; SMC, Scottish Medicines Consortium

     

    PP-NUB-GB-2548 | August 2025